MSH6 and neoplasm: However careful consideration of previous studies is required as part of the conclusions are based on MSH6 missense mutations of unknown pathogenecity or testing a sporadic tumour within an HNPCC family (a phenocopy) as suggested by positive immunostaining of MSH6 in the tumour.